1. Home
  2. MHK vs RGEN Comparison

MHK vs RGEN Comparison

Compare MHK & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mohawk Industries Inc.

MHK

Mohawk Industries Inc.

HOLD

Current Price

$112.40

Market Cap

6.4B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$157.57

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHK
RGEN
Founded
1988
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
8.2B
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
MHK
RGEN
Price
$112.40
$157.57
Analyst Decision
Buy
Buy
Analyst Count
11
10
Target Price
$138.00
$170.90
AVG Volume (30 Days)
834.6K
696.6K
Earning Date
10-23-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
6.71
0.03
Revenue
$10,722,900,000.00
$707,890,000.00
Revenue This Year
$0.30
$17.84
Revenue Next Year
$2.24
$12.57
P/E Ratio
$16.76
$6,185.26
Revenue Growth
N/A
11.74
52 Week Low
$96.24
$102.97
52 Week High
$143.13
$182.52

Technical Indicators

Market Signals
Indicator
MHK
RGEN
Relative Strength Index (RSI) 50.12 47.50
Support Level $106.06 $160.11
Resistance Level $114.21 $165.02
Average True Range (ATR) 2.98 4.97
MACD 0.45 -1.27
Stochastic Oscillator 56.76 7.12

Price Performance

Historical Comparison
MHK
RGEN

About MHK Mohawk Industries Inc.

Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: